CV2 (CRMP5) Antibodies

Screening for antibodies against the CV2 antigen is used in the investigation of patients with possible paraneoplastic syndrome.

Antibodies against the CV2 antigen are a paraneoplastic marker that is mainly associated with small cell lung cancer but can also be found in patients with thymoma and other types of tumors. Clinical symptoms may include chorea, sensor-motor neuropathy, limbic encephalitis, and cerebral degeneration. Neurological symptoms can precede the diagnosis of cancer up to five years earlier.

See also: Anti-Neuronal Antibodies

Measurement for the presence of CV2 antibodies (CRMP5) is performed by taking a blood sample which can be done:

• At Diagnostiki Athinon - By taking a blood sample in Diagnostiki Athinon. There is no need for prior fasting. Book your appointment in real time and purchase the test online.